Dr Reddy’s Lab Q2 profit up 69 pc at Rs 690 crore

October 31, 2013 03:41 pm | Updated 03:41 pm IST - New Delhi

Drug major Dr Reddy’s Laboratories on Thursday reported a 69.41 per cent increase in consolidated net profit at Rs 690.25 crore for the second quarter ended September 30.

The company had posted a profit of Rs 407.44 crore in the same period of the previous financial year.

Net sales rose to Rs 3,357.45 crore from Rs 2,880.85 crore a year earlier, Dr Reddy’s Laboratories said in a BSE filing. Revenue from the global generics segment grew 32 per cent to Rs 2,654.78 crore, driven by North America, Russia and other emerging markets, the company said.

Shares of Dr Reddy’s Laboratories were down 2.52 per cent at Rs 2,459.20 on the BSE in late afternoon trade.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.